These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11121228)

  • 1. Vitamin D resistance in RAS-transformed keratinocytes: mechanism and reversal strategies.
    Solomon C; Kremer R; White JH; Rhim JS
    Radiat Res; 2001 Jan; 155(1 Pt 2):156-162. PubMed ID: 11121228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examination of VDR/RXR/DRIP205 Interaction, Intranuclear Localization, and DNA Binding in Ras-Transformed Keratinocytes and Its Implication for Designing Optimal Vitamin D Therapy in Cancer.
    Jusu S; Presley JF; Williams C; Das SK; Jean-Claude B; Kremer R
    Endocrinology; 2018 Mar; 159(3):1303-1327. PubMed ID: 29300860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitogen-activated protein kinase inhibits 1,25-dihydroxyvitamin D3-dependent signal transduction by phosphorylating human retinoid X receptor alpha.
    Solomon C; White JH; Kremer R
    J Clin Invest; 1999 Jun; 103(12):1729-35. PubMed ID: 10377179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation of Human Retinoid X Receptor α at Serine 260 Impairs Its Subcellular Localization, Receptor Interaction, Nuclear Mobility, and 1α,25-Dihydroxyvitamin D3-dependent DNA Binding in Ras-transformed Keratinocytes.
    Jusu S; Presley JF; Kremer R
    J Biol Chem; 2017 Jan; 292(4):1490-1509. PubMed ID: 27852823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation of the human retinoid X receptor alpha at serine 260 impairs coactivator(s) recruitment and induces hormone resistance to multiple ligands.
    Macoritto M; Nguyen-Yamamoto L; Huang DC; Samuel S; Yang XF; Wang TT; White JH; Kremer R
    J Biol Chem; 2008 Feb; 283(8):4943-56. PubMed ID: 18003614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption of vitamin D receptor-retinoid X receptor heterodimer formation following ras transformation of human keratinocytes.
    Solomon C; Sebag M; White JH; Rhim J; Kremer R
    J Biol Chem; 1998 Jul; 273(28):17573-8. PubMed ID: 9651351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1Alpha,25-dihydroxyvitamin D3-mediated stimulation of steroid sulphatase activity in myeloid leukaemic cell lines requires VDRnuc-mediated activation of the RAS/RAF/ERK-MAP kinase signalling pathway.
    Hughes PJ; Brown G
    J Cell Biochem; 2006 Jun; 98(3):590-617. PubMed ID: 16440327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constitutive activation of the mitogen-activated protein kinase pathway impairs vitamin D signaling in human prostate epithelial cells.
    Zhang Z; Kovalenko P; Cui M; Desmet M; Clinton SK; Fleet JC
    J Cell Physiol; 2010 Aug; 224(2):433-42. PubMed ID: 20432439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective recognition of vitamin D receptor conformations mediates promoter selectivity of vitamin D analogs.
    Quack M; Carlberg C
    Mol Pharmacol; 1999 Jun; 55(6):1077-87. PubMed ID: 10347251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
    Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
    J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural variants of the vitamin D analogue EB1089 reduce its ligand sensitivity and promoter selectivity.
    Quack M; Clarin A; Binderup E; Björkling F; Hansen CM; Carlberg C
    J Cell Biochem; 1998 Dec; 71(3):340-50. PubMed ID: 9831071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced coactivator binding and transcriptional activation of mutant vitamin D receptors from patients with hereditary 1,25-dihydroxyvitamin D-resistant rickets by phosphorylation and vitamin D analogs.
    Liu Y; Shen Q; Malloy PJ; Soliman E; Peng X; Kim S; Pike JW; Feldman D; Christakos S
    J Bone Miner Res; 2005 Sep; 20(9):1680-91. PubMed ID: 16059639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanistic studies to evaluate the enhanced antiproliferation of human keratinocytes by 1alpha,25-dihydroxyvitamin D(3)-3-bromoacetate, a covalent modifier of vitamin D receptor, compared to 1alpha,25-dihydroxyvitamin D(3).
    Chen ML; Ray S; Swamy N; Holick MF; Ray R
    Arch Biochem Biophys; 1999 Oct; 370(1):34-44. PubMed ID: 10496974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of vitamin D analog-induced heterodimerization of vitamin D receptor with retinoid X receptor using the yeast two-hybrid system.
    Zhao XY; Eccleshall TR; Krishnan AV; Gross C; Feldman D
    Mol Endocrinol; 1997 Mar; 11(3):366-78. PubMed ID: 9058382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New understanding of the molecular mechanism of receptor-mediated genomic actions of the vitamin D hormone.
    Haussler MR; Jurutka PW; Hsieh JC; Thompson PD; Selznick SH; Haussler CA; Whitfield GK
    Bone; 1995 Aug; 17(2 Suppl):33S-38S. PubMed ID: 8579895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol potentiates vitamin D and nuclear receptor signaling.
    Dampf Stone A; Batie SF; Sabir MS; Jacobs ET; Lee JH; Whitfield GK; Haussler MR; Jurutka PW
    J Cell Biochem; 2015 Jun; 116(6):1130-43. PubMed ID: 25536521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
    Kim S; Shevde NK; Pike JW
    J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of nuclear vitamin D receptor resistance in Harvey-ras-transfected cells.
    Taber LM; Adams LS; Teegarden D
    J Nutr Biochem; 2009 Aug; 20(8):629-37. PubMed ID: 18829283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of two novel 14-epivitamin D3 analogs with vitamin D3 receptor-retinoid X receptor heterodimers on vitamin D3 responsive elements.
    Verlinden L; Verstuyf A; Quack M; Van Camp M; Van Etten E; De Clercq P; Vandewalle M; Carlberg C; Bouillon R
    J Bone Miner Res; 2001 Apr; 16(4):625-38. PubMed ID: 11315990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiproliferative Activity of Non-Calcemic Vitamin D Analogs on Human Melanoma Lines in Relation to VDR and PDIA3 Receptors.
    Wasiewicz T; Piotrowska A; Wierzbicka J; Slominski AT; Zmijewski MA
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30200275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.